Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological response to a Staphylococcus aureus fibronectin-binding protein.

P Ciborowski1, J I Flock, T Wadström

  • 1Department of Medical Microbiology, University of Lund, Sweden.

Journal of Medical Microbiology
|December 1, 1992
PubMed
Summary

This study developed a stable fusion protein, gal-FnBP, for potential vaccine development. Antibodies generated against it effectively blocked bacterial adhesion, indicating its promise as a vaccine component.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prebiotic preferences of human lactobacilli strains in co-culture with bifidobacteria and antimicrobial activity against Clostridium difficile.

Journal of applied microbiology·2015
Same author

Plasma gelsolin accumulates in macrophage nodules in brains of simian immunodeficiency virus infected rhesus macaques.

Journal of neurovirology·2012
Same author

Participation of cell-surface hydrophobins for hemin binding in Helicobacter pylori.

Folia microbiologica·2011
Same author

Methods for the Identification of H. pylori Host Receptors.

Methods in molecular medicine·2011
Same author

Mass spectrometric characterization of gelsolin isoforms.

Rapid communications in mass spectrometry : RCM·2010
Same author

Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment.

Journal of neurovirology·2008

Area of Science:

  • Microbiology and Immunology
  • Protein Engineering
  • Vaccine Development

Background:

  • Staphylococcus aureus fibronectin-binding protein (FnBP) mediates bacterial attachment to host tissues.
  • Native FnBP has limitations in stability and production yield.
  • A fusion protein, gal-FnBP, was engineered to enhance stability and production.

Purpose of the Study:

  • To assess the potential of gal-FnBP as a vaccine component.
  • To evaluate the immunogenicity and antibody response against gal-FnBP.
  • To determine the functional capacity of generated antibodies in blocking fibronectin binding.

Main Methods:

  • Construction of a fusion protein (gal-FnBP) combining beta-galactosidase and FnBP binding domains.
  • Western blot analysis to confirm binding specificity.

Related Experiment Videos

  • Formalin treatment to inactivate binding capacity while retaining immunogenicity.
  • Immunization of mice with treated and untreated gal-FnBP.
  • Blocking assay to measure antibody-mediated inhibition of fibronectin binding.

    • Main Results:

    • Formalin treatment inactivated gal-FnBP binding but preserved immunogenicity.
    • Immunization induced high antibody titers against the fibronectin-binding domain.
    • Antibodies from immunized mice blocked fibronectin binding to gal-FnBP by 40% (formalin-treated) and 25% (non-treated).

    Conclusions:

    • Gal-FnBP is a stable and producible fusion protein with potential as a vaccine candidate.
    • Formalin-treated gal-FnBP elicits functional antibodies capable of inhibiting fibronectin binding.
    • This approach shows promise for developing vaccines against FnBP-mediated bacterial adhesion.